Evidence map›Paper›PMID 23201556›Full record

ArticleBiochimie2013

Hydroxylamine acutely activates glucose uptake in L929 fibroblast cells.

Larry L Louters, Jared P Scripture, David P Kuipers, Stephen M Gunnink, Benjamin D Kuiper, Ola D Alabi

Open access · greenAbstract read
In one paragraph

Article in Biochimie, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Larry L LoutersDepartment of Chemistry and Biochemistry, Calvin College, Grand Rapids, MI 49546, USA. lout@calvin.edu
Jared P Scripture
David P Kuipers
Stephen M Gunnink
Benjamin D Kuiper
Ola D Alabi
Calvin University · US

Funding

The Mechanism for the Acute Activation of GLUT1R15DK081931 · NIDDK · CALVIN UNIVERSITY · PI LOUTERS, LAURENCE LEON · 2009 to 2014
$600k
NIDDK NIH HHS DK08193-1A1NIDDK NIH HHS R15 DK081931
6 · The paper itself

Abstract

Nitroxyl (HNO) has a unique, but varied, set of biological properties including beneficial effects on cardiac contractility and stimulation of glucose uptake by GLUT1. These biological effects are largely initiated by HNO's reaction with cysteine residues of key proteins. The intracellular production of HNO has not yet been demonstrated, but the small molecule, hydroxylamine (HA), has been suggested as possible intracellular source. We examined the effects of this molecule on glucose uptake in L929 fibroblast cells. HA activates glucose uptake from 2 to 5-fold within two minutes. Prior treatment with thiol-active compounds, such as iodoacetamide (IA), cinnamaldehyde (CA), or phenylarsine oxide (PAO) blocks HA-activation of glucose uptake. Incubation of HA with the peroxidase inhibitor, sodium azide, also blocks the stimulatory effects of HA. This suggests that HA is oxidized to HNO by L929 fibroblast cells, which then reacts with cysteine residues to exert its stimulatory effects. The data suggest that GLUT1 is acutely activated in L929 cells by modification of cysteine residues, possibly the formation of a disulfide bond within GLUT1 itself.

Indexed as

AcroleinAnimalsArsenicalsAzidesBiological TransportCell LineDose-Response Relationship, DrugFibroblastsGlucoseGlucose Transporter Type 1HydroxylamineIodoacetamideMiceTime FactorsAcroleinArsenicalsAzidescinnamaldehydeGlucoseGlucose Transporter Type 1HydroxylamineIodoacetamideoxophenylarsine

Identifiers

PMID23201556
PMCPMC3594047
OpenAlexW2008011075

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.